Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

GW24-e2211 Protective effects of aliskiren on ischaemia-reperfusion-induced renal injury in rats

View through CrossRef
Objectives The protective effect of aliskiren on ischaemia-reperfusion (I/R) injury in the heart and brain has been reported. Whether or not the protective effect exists in renal I/R injury is not known. Therefore, we investigated this effect in kidney in this study. Methods Sprague-Dawley rats were randomly divided into four groups: sham group; sham control with aliskiren pretreatment; I/R group; I/R with aliskiren pretreatment. Renal ischaemia was induced by occluding the left renal pedicle, and maintained ischaemia for 45 min, the reperfusion lasted for 24 hrs. Aliskiren was administrated 15 min before ischaemia. Blood samples and the kidneys were collected to check for renal function, angiotensin II (Ang II), apoptosis and oxidative stress levels. Results Compared with the sham rats, serum creatinine (SCR) and blood urea nitrogen (BUN) were significantly increased in I/R rats, accompanied by histopathological damage ofthe kidney, including tubular cell swelling, desquamation, and cast formation. There were more apoptotic cells and leukocyte infiltration in I/R rats than in the sham rats. Pretreatment with aliskiren ameliorated I/R induced renalinjury, i.e. reduced SCR and BUN levels, ameliorated renal histopahological changes, and decreased the apoptosis of cells and leukocyte infiltration in kidney. I/R injury also decreased superoxide dismutase (SOD) and glutathione (GSH-reduced form) levels, which were blocked with the aliskiren pretreatment. Conclusions Aliskiren pretreatment exerts a protective effect on ischaemia/reperfusion injury in the kidney, via amelioration of oxidative stress, and reduction in leukocyte infiltration and cellular apoptosis.
Title: GW24-e2211 Protective effects of aliskiren on ischaemia-reperfusion-induced renal injury in rats
Description:
Objectives The protective effect of aliskiren on ischaemia-reperfusion (I/R) injury in the heart and brain has been reported.
Whether or not the protective effect exists in renal I/R injury is not known.
Therefore, we investigated this effect in kidney in this study.
Methods Sprague-Dawley rats were randomly divided into four groups: sham group; sham control with aliskiren pretreatment; I/R group; I/R with aliskiren pretreatment.
Renal ischaemia was induced by occluding the left renal pedicle, and maintained ischaemia for 45 min, the reperfusion lasted for 24 hrs.
Aliskiren was administrated 15 min before ischaemia.
Blood samples and the kidneys were collected to check for renal function, angiotensin II (Ang II), apoptosis and oxidative stress levels.
Results Compared with the sham rats, serum creatinine (SCR) and blood urea nitrogen (BUN) were significantly increased in I/R rats, accompanied by histopathological damage ofthe kidney, including tubular cell swelling, desquamation, and cast formation.
There were more apoptotic cells and leukocyte infiltration in I/R rats than in the sham rats.
Pretreatment with aliskiren ameliorated I/R induced renalinjury, i.
e.
reduced SCR and BUN levels, ameliorated renal histopahological changes, and decreased the apoptosis of cells and leukocyte infiltration in kidney.
I/R injury also decreased superoxide dismutase (SOD) and glutathione (GSH-reduced form) levels, which were blocked with the aliskiren pretreatment.
Conclusions Aliskiren pretreatment exerts a protective effect on ischaemia/reperfusion injury in the kidney, via amelioration of oxidative stress, and reduction in leukocyte infiltration and cellular apoptosis.

Related Results

GW24-e3848 The organ protective effect of direct renin inhibitor in a mouse model of type 2 diabetes
GW24-e3848 The organ protective effect of direct renin inhibitor in a mouse model of type 2 diabetes
Objectives The benefit of blocking the renin-angiotensin system (RAS) with conventional RAS blockers in cardiovascular diseases and nephropathy of patients with t...
A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension
A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension
Aliskiren is a novel antihypertensive agent and the first direct renin inhibitor (DRI) in clinical use. Several clinical trials have compared DRI with angiotensin receptor blockers...
e0352 Efficacy and safety of aliskiren in chinese patients with mild or moderate essential hypertension
e0352 Efficacy and safety of aliskiren in chinese patients with mild or moderate essential hypertension
To assess the antihypertensive efficacy and safety of aliskiren compared with ramipril in Chinese patients with mild or moderate essential hypertension. ...
e0078 The effect of acute atorvastatin on cardioprotection of ischaemic postconditioning in diabetes mellitus
e0078 The effect of acute atorvastatin on cardioprotection of ischaemic postconditioning in diabetes mellitus
Objective This study was to investigate if the low dose of acute atorvastatin treatment could affect the cardioprotection of ischaemic post-conditioning (Ipost) i...
GW24-e3829 The role of CD59 in mouse cerebral ischaemia-reperfusion injury
GW24-e3829 The role of CD59 in mouse cerebral ischaemia-reperfusion injury
Objectives To investigate dynamic changes of complement regulatory protein CD59 expression and discuss its possible mechanisms. During cerebral ischaemia-reperfus...

Back to Top